Compliance Genetic Engineering Genetics 
Advarra
JUNE 12, 2023
IBCs, however, seek to protect study personnel, the community, and the environment from exposure to engineered genetic material and other biohazardous agents. The IBC’s review is intended to ensure a thorough risk assessment is performed regarding the risks associated with the genetically modified materials.
Pharmaceutical Technology
JUNE 29, 2022
We also benefit from having cGMP manufacturing capabilities in compliance with global regulatory requirements, a strong heritage from our mother company’s brand, a proven track record of reliable and secure supply, and a new partner that is probably the best player in the market within enzyme diversity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WCG Clinical
AUGUST 27, 2024
1 This is an important requirement, as the NIH Guidelines were originally created partly in response to public concerns surrounding recombinant DNA and genetic engineering. Many of those original concerns of the 1970s and 1980s surrounding genetic engineering have lessened over time.
WCG Clinical
NOVEMBER 17, 2023
Since then, however, certain genetic engineering technologies (e.g., For example, two trials testing genetically identical genome-edited cell therapies – one engineered with a viral vector, and one without – can differ in their IBC review requirements because of how the cells were modified rather than what they have become.
Cloudbyz
MARCH 5, 2024
Administration and Dosage: Due to their nature, biologics are often administered via injection or infusion, which can affect patient compliance and convenience. Ensuring batch-to-batch consistency is a significant challenge. Determining the optimal dosage and administration route is more challenging.
Advarra
OCTOBER 26, 2023
Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines.
ACRP blog
OCTOBER 8, 2024
This article will discuss how the new proposed sIRB mandate would impact institutions which currently use their local IRB for review of this research and how to prepare for compliance with the potential new regulation. Her graduate training was in genetic engineering, which led to an interest in medical diagnostic device technology.
Expert insights. Personalized for you.
98 
Let's personalize your content